INTERLEUKIN-1-ALPHA, TUMOR-NECROSIS-FACTOR-ALPHA, AND INTERFERON-GAMMA IN PSORIASIS

被引:83
作者
GOMI, T
SHIOHARA, T
MUNAKATA, T
IMANISHI, K
NAGASHIMA, M
机构
[1] KYORIN UNIV,SCH MED,DEPT DERMATOL,6-20-2 SHINKAWA,MITAKA,TOKYO 181,JAPAN
[2] INST KOHTOHBIKEN TOHOKU SPECIAL ANAL LABS,TOKYO,JAPAN
[3] TOKYO WOMENS MED COLL,DEPT MICROBIOL,TOKYO 162,JAPAN
关键词
D O I
10.1001/archderm.127.6.827
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Although recent studies have suggested that a variety of cytokines released by keratinocytes and inflammatory leukocytes could contribute to induction or persistence of the inflammatory processes in psoriasis, it remains unclear how production of these cytokines is regulated in psoriatic patients. To elucidate the biologic relevance of these cytokines to the pathogenesis of psoriasis, we investigated serum levels of interleukin 1-alpha, tumor necrosis factor-alpha, and interferon-gamma in 21 patients with psoriasis vulgaris, together with 21 healthy controls. The mean serum levels of interleukin 1-alpha and tumor necrosis factor-alpha were not significantly different from those in controls, while those of interferon-gamma were significantly elevated in the patients with psoriasis. Serum levels of interleukin 1-alpha correlated negatively with clinical disease severity expressed as psoriasis area and severity index score and with duration of psoriasis. In contrast, interferon-gamma levels were related, although not significantly, to disease severity. In addition, an inverse correlation was noted between the interleukin 1-alpha levels and interferon-gamma levels. These results indicate that interleukin 1-alpha and interferon-gamma may be relevant to the induction and perpetuation, respectively, of the inflammatory responses in psoriasis, and that these cytokines, which have similar biologic properties, may strictly regulate one another's production in vivo.
引用
收藏
页码:827 / 830
页数:4
相关论文
共 18 条
[1]  
CAMP RDR, 1986, J IMMUNOL, V137, P3469
[2]   PSORIASIS INDUCED AT THE INJECTION SITE OF RECOMBINANT INTERFERON-GAMMA - RESULTS OF IMMUNOHISTOLOGIC INVESTIGATIONS [J].
FIERLBECK, G ;
RASSNER, G ;
MULLER, C .
ARCHIVES OF DERMATOLOGY, 1990, 126 (03) :351-355
[3]   SEVERE PSORIASIS - ORAL THERAPY WITH A NEW RETINOID [J].
FREDRIKSSON, T ;
PETTERSSON, U .
DERMATOLOGICA, 1978, 157 (04) :238-244
[4]   TUMOR NECROSIS FACTOR AND INTERLEUKIN-1 IN THE SERUM OF CHILDREN WITH SEVERE INFECTIOUS PURPURA [J].
GIRARDIN, E ;
GRAU, GE ;
DAYER, JM ;
ROUXLOMBARD, P ;
LAMBERT, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (07) :397-400
[5]  
HAMMERBERG C, 1989, J INVEST DERMATOL, V92, P439
[6]   SURFACE-ANTIGENS OF MELANOMA AND MELANOCYTES - SPECIFICITY OF INDUCTION OF IA ANTIGENS BY HUMAN GAMMA-INTERFERON [J].
HOUGHTON, AN ;
THOMSON, TM ;
GROSS, D ;
OETTGEN, HF ;
OLD, LJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (01) :255-269
[7]  
Kupper T S, 1988, Adv Dermatol, V3, P293
[8]  
KUPPER TS, 1989, J INVEST DERMATOL, V92, P466
[10]   INTERFERONS AND PSORIASIS - 1987 PERSPECTIVE [J].
NICKOLOFF, BJ .
DERMATOLOGICA, 1987, 175 (01) :1-4